Lung cancer study hints at new treatments
Studying the most common type of lung cancer, researchers from The Cancer Genome Atlas have uncovered new mutations in a cell-signaling pathway that plays a role in forming tumors. The new knowledge may expand treatments for patients because drugs targeting some of these genetic changes already are available or are in clinical trials.
Detailed picture of ovarian cancer emerges
School of Medicine scientists, including Richard Wilson, PhD, have completed the largest analysis to date of the genetic mutations underlying ovarian cancer.